Related Experiment Video
Updated: Oct 11, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Therapeutic adherence in hypertension: Current evidence and expert opinion from India
Jamshed J Dalal1, Prafulla Kerkar2, Santanu Guha3
1Centre for Cardiac Sciences, Kokilaben Dhirubhai Ambani Hospital, Mumbai, India.
Insights
Improving hypertension (HTN) treatment adherence in India requires addressing socioeconomic factors, health literacy, and patient-physician communication. A multipronged approach involving patients, physicians, and health systems is crucial for better cardiovascular outcomes.
Area of Science:
- Cardiology
- Public Health
- Health Services Research
Background:
- Hypertension (HTN) is a major global non-communicable disease linked to significant cardiovascular (CV) morbidity and mortality.
- Therapeutic adherence is critical for effective HTN management and CV outcome improvement.
- Adherence rates to antihypertensive medications in India vary widely, influenced by numerous patient- and system-level factors.
Purpose of the Study:
- To identify key determinants of antihypertensive treatment adherence in the Indian context.
- To explore strategies for improving therapeutic adherence in patients with hypertension.
- To emphasize the role of patient education, physician-patient communication, and healthcare accessibility in managing HTN.
Main Methods:
- Review of studies focusing on adherence to antihypertensive medications in India.
- Analysis of factors influencing treatment adherence, including socioeconomic status, health literacy, and disease characteristics.
- Exploration of multifaceted strategies for enhancing adherence.
Main Results:
- Adherence is influenced by socioeconomic status, health literacy, disease duration, forgetfulness, and medication costs.
- An effective physician-patient relationship and counseling are vital for identifying and addressing poor adherence.
- A multipronged approach targeting physicians, patients, and health systems is necessary for improvement.
Conclusions:
- Improving HTN therapeutic adherence in India necessitates enhanced patient education, stronger physician-patient communication, increased healthcare access, and affordability.
- The pharmaceutical sector can contribute through therapeutic innovations.
- Increased adherence to lifestyle interventions is also key for better HTN control and CV outcomes.
Abstract:
Hypertension (HTN) is a globally prevalent non-communicable disease contributing significantly to cardiovascular (CV) morbidity and mortality. In achieving control of HTN, therapeutic adherence plays a crucial role. Studies from India identify varying rates of adherence to antihypertensive medications. Multiple factors determine treatment adherence in HTN. In India, factors such as lower socioeconomic status, health literacy, asymptomatic nature of disease, forgetfulness, cost of medications, and duration of HTN determine the adherence. An excellent physician-patient relationship incorporating adequate counseling along with the use of other methods can identify poor adherence. Improving adherence necessitates incorporating a multipronged approach with strategies directed at physicians, patients, and health systems. With innovation in therapeutics, the pharmaceutical sector can contribute significantly to improve adherence. Furthermore, increasing adherence to lifestyle interventions can help achieve better HTN control and improve CV outcomes. In the Indian context, more emphasis is necessary on patient education, enhanced physician-patient relationship and communication, increased access to health care, and affordability in improving therapeutic adherence in HTN.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Hypertension and Regulation of Blood Pressure
Errors occurring during blood pressure monitoring
Several factors...

